Cart
sales@molnova.com
(2-phenylethyl)hydrazine dihydrochloride
CAS No. 16904-30-6
(2-phenylethyl)hydrazine dihydrochloride( —— )
Catalog No. M28381 CAS No. 16904-30-6
(2-phenylethyl)hydrazine dihydrochloride is a chemical compound.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | Get Quote |
|
| 10MG | 68 | Get Quote |
|
| 25MG | 115 | Get Quote |
|
| 50MG | 173 | Get Quote |
|
| 100MG | 258 | Get Quote |
|
| 200MG | 388 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name(2-phenylethyl)hydrazine dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief Description(2-phenylethyl)hydrazine dihydrochloride is a chemical compound.
-
Description(2-phenylethyl)hydrazine dihydrochloride is a chemical compound.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPI3Kα|PI3Kδ|PI3Kγ|PI3Kβ|Abl1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number16904-30-6
-
Formula Weight209.11
-
Molecular FormulaC8H14Cl2N2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.Cl.NNCCc1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Stephen Cosenza, et al. Targeting oncogenic STAT3 and STAT5 signaling with on 146040, a small molecule inhibitor of PI3K α/δ and BCR-ABL. Journal of Clinical Oncology 2014 32:15
molnova catalog
related products
-
ML-354
ML354 is a selective antagonist of PAR4 with an IC50 of 140 nM .
-
(1R,2R)-2-PCCA hydro...
(1R,2R)-2-PCCA hydrochloride is a potent, selective, and blood-brain-barrier-crossing GPR88 receptor agonist with an EC50 value of 1140 n in striatal membranes of WT mice; it can be used to study the central nervous system.
-
1-Hydroxypinoresinol...
(+)-1-Hydroxypinoresinol 1-O-beta-D-glucoside exhibits peroxynitrite, total ROS and DPPH radical scavenging activities with IC50 values of 3.23 +/- 0.04, 2.26 +/- 0.07 and 32.3 +/- 0.13 microM, respectively.
